These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34952739)

  • 1. CRISPR-based therapeutics: current challenges and future applications.
    Modell AE; Lim D; Nguyen TM; Sreekanth V; Choudhary A
    Trends Pharmacol Sci; 2022 Feb; 43(2):151-161. PubMed ID: 34952739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applications.
    Li Y; Glass Z; Huang M; Chen ZY; Xu Q
    Biomaterials; 2020 Mar; 234():119711. PubMed ID: 31945616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Genome Editing and In Vivo Delivery.
    Ramirez-Phillips AC; Liu D
    AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for Optimization of the Clustered Regularly Interspaced Short Palindromic Repeat-Based Genome Editing System for Enhanced Editing Specificity.
    Wang YM; Wang HZ; Jian YZ; Luo ZT; Shao HW; Zhang WF
    Hum Gene Ther; 2022 Apr; 33(7-8):358-370. PubMed ID: 34963339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in therapeutic application of CRISPR-Cas9.
    Sun J; Wang J; Zheng D; Hu X
    Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential.
    Oude Blenke E; Evers MJ; Mastrobattista E; van der Oost J
    J Control Release; 2016 Dec; 244(Pt B):139-148. PubMed ID: 27498021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Various Aspects of a Gene Editing System-CRISPR-Cas9.
    Janik E; Niemcewicz M; Ceremuga M; Krzowski L; Saluk-Bijak J; Bijak M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
    Eid A; Mahfouz MM
    Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for
    Wei T; Cheng Q; Farbiak L; Anderson DG; Langer R; Siegwart DJ
    ACS Nano; 2020 Aug; 14(8):9243-9262. PubMed ID: 32697075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
    Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease.
    Baker C; Hayden MS
    F1000Res; 2020; 9():281. PubMed ID: 32528662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in CRISPR/Cas9 Technology for in Vivo Translation.
    Çiçek YA; Luther DC; Kretzmann JA; Rotello VM
    Biol Pharm Bull; 2019; 42(3):304-311. PubMed ID: 30828060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Off-Target Detection for CRISPR-Based Genome Editing.
    Wang H; Wang Y; Luo Z; Lin X; Liu M; Wu F; Shao H; Zhang W
    Hum Gene Ther; 2023 Feb; 34(3-4):112-128. PubMed ID: 36453226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy.
    Wu HY; Cao CY
    Brief Funct Genomics; 2019 Mar; 18(2):129-132. PubMed ID: 29579146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas based gene editing: marking a new era in medical science.
    Prasad K; George A; Ravi NS; Mohankumar KM
    Mol Biol Rep; 2021 May; 48(5):4879-4895. PubMed ID: 34143395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Base Editing: The Ever Expanding Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Tool Kit for Precise Genome Editing in Plants.
    Monsur MB; Shao G; Lv Y; Ahmad S; Wei X; Hu P; Tang S
    Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32344599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9 a simple, inexpensive and effective technique for gene editing.
    Ferreira P; Choupina AB
    Mol Biol Rep; 2022 Jul; 49(7):7079-7086. PubMed ID: 35716290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas systems: Challenges and future prospects.
    Gohil N; Bhattacharjee G; Lam NL; Perli SD; Singh V
    Prog Mol Biol Transl Sci; 2021; 180():141-151. PubMed ID: 33934835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.